Evaluation of the immunogenicity and impact on the latent HIV-1 reservoir of a conserved region vaccine, MVA.HIVconsv, in antiretroviral therapy-treated subjects

Lignende værker

• Early Kinetics of the HLA Class I-Associated Peptidome of MVA.HIVconsv-Infected Cells
  af: Ternette, Nicola, et al.
  Udgivet: (2015)
• Absence of systemic toxicity changes following intramuscular administration of novel pSG2.HIVconsv DNA, ChAdV63.HIVconsv and MVA.HIVconsv vaccines to BALB/c mice()
  af: Ondondo, Beatrice, et al.
  Udgivet: (2013)
• HIVconsv Vaccines and Romidepsin in Early-Treated HIV-1-Infected Individuals: Safety, Immunogenicity and Effect on the Viral Reservoir (Study BCN02)
  af: Mothe, Beatriz, et al.
  Udgivet: (2020)
• Sensitive quantification of the HIV-1 reservoir in gut-associated lymphoid tissue
  af: Morón-López, Sara, et al.
  Udgivet: (2017)
• Recombinant DNA/MVA/ChAdV-63-elicited T cells specific for conserved regions of the HIV-1 proteome recognize HIV-1 infected cells and suppress HIV-1
  af: Ahmed T, et al.
  Udgivet: (2012-09-01)